转移相关蛋白1:在癌症治疗中是一种可用药物的点
Madhusudana Pulaganti1, Kireeti Anthati Soma2, Rekha Mandla1
1Multidisciplinary Research Unit, Sri Venkateswara Medical College, Tirupati, India.
Korean journal of clinical oncology
|May 9, 2025
概括
转移相关蛋白1 (MTA1) 是新型癌症治疗的有希望的可用药物标. 针对MTA1提供了在精密瘤学中具有更少副作用的更有效治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 分子向药物代表了癌症治疗的范式转变,专注于特定的癌症细胞脆弱性.
- 识别可用药的点对于开发有效的疗法至关重要,以尽量减少对正常组织的伤害.
研究的目的:
- 提供转移相关蛋白1 (MTA1) 作为癌症治疗中可用药物的标的概述.
- 突出MTA1在癌症进展中的作用及其作为预测生物标志物的潜力.
- 探索精密瘤学中MTA1抑制的未来策略.
主要方法:
- 对MTA1在各种恶性瘤中的功能进行文献综述和分析.
- 检查MTA1在基因表达调节,染色质重塑和上皮-介质细胞转换中的作用.
- 评估MTA1作为预测治疗反应的生物标志物的潜力.
主要成果:
- MTA1在癌症进展中发挥着多方面的作用,包括促进瘤生长和转移.
- MTA1具有作为患者对向疗法的反应预测生物标志物的潜力.
- 抑制MTA1是开发新型癌症治疗的可行策略.
结论:
- MTA1是一个重要的可用药物点,对癌症治疗有广泛的影响.
- 准MTA1为开发具有提高疗效和降低毒性的创新治疗提供了一个有希望的途径.
- 了解MTA1的药物潜力可以为癌症患者带来更好的临床结果.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


